Ocuphire Pharma Inc — Company Overview, News & Financial Data

Ocuphire Pharma (NASDAQ: OCUP) focuses on developing and commercializing therapies for eye disorders. Specializing in innovative ophthalmic solutions, Ocuphire addresses significant unmet medical needs in conditions like night vision disturbances and presbyopia. Key projects include its lead candidate, Nyxol, an eye drop formulation targeting multiple indications. The company's objectives revolve around advancing Nyxol through clinical trials and gaining regulatory approvals to bring these therapies to the market. Ocuphire is driven by a commitment to improving the quality of life for patients with vision problems through groundbreaking research and collaboration with healthcare professionals.